Predictive Validation and the Re-Analysis of Cost-Effectiveness: Do We Dare to Tread?

Jonathan Karnon () and Hossein Hajiali Afzali
Additional contact information
Jonathan Karnon: University of Adelaide
Hossein Hajiali Afzali: University of Adelaide

PharmacoEconomics, 2017, vol. 35, issue 11, No 1, 1112 pages

Date: 2017
References: Add references at CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s40273-017-0561-x Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:pharme:v:35:y:2017:i:11:d:10.1007_s40273-017-0561-x

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/40273

DOI: 10.1007/s40273-017-0561-x

Access Statistics for this article

PharmacoEconomics is currently edited by Timothy Wrightson and Christopher I. Carswell

More articles in PharmacoEconomics from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().